VFA
MYOV

Values First Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

Values First Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-32,818
Closed -$248K – 145
2020
Q1 		$248K Sell
32,818
-39,599
-55% -$444K 0.3% 99
2019
Q4 		$1.12M Buy
+72,417
New +$730K 1.09% 38

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Values First Advisors's MYOV Position: Q2 2020 in Review

Values First Advisors sold out of Myovant Sciences Ltd. (MYOV) in Q2 2020, closing a stake of 32,818 shares — an estimated $248K sold.

Values First Advisors first reported a position in MYOV in Q4 2019 and held it in 2 quarters. The position peaked at $1.12M in Q4 2019. 96 funds tracked by Wall St. Rank hold MYOV as of Q2 2020.

  • Values First Advisors reported no remaining Myovant Sciences Ltd. position as of Q2 2020 after selling out during the quarter.
  • Values First Advisors sold 32,818 Myovant Sciences Ltd. shares in Q2 2020, an estimated $248K.
  • Values First Advisors first reported a position in Myovant Sciences Ltd. in Q4 2019 and held it in 2 quarters.
  • Values First Advisors's Myovant Sciences Ltd. position peaked at $1.12M in Q4 2019.
  • 96 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2020.

Based on Values First Advisors's 13F filing for Q2 2020, filed 15 Nov 2022.